Biological Science: Cell/Genetics (Volume 1) Reviews
August 23, 2010 by biotech-source.com · 5 Comments
Biological Science: Cell/Genetics (Volume 1)
Infused with the spirit of inquiry, Freeman’s Biological Science helps teach readers the fundamentals while introducing them to the excitement that drives the science. By presenting unifying concepts and methods of analysis, this book helps its readers learn to think like biologists and gives them the tools they need for success in understanding more advanced subjects. Volume I of a nine-part organization covers topics under the general headings of: the origin and early evolution of life, cell functions, gene structure and expression, developmental biology, evolutionary patterns and processes, the diversification of life, how plants work, how animals work, and ecology. For science enthusiasts who want to be inspired with a sense of wonder and excitement that makes learning about biology interesting and fun.
Rating:
(out of 20 reviews)
List Price: $ 54.67
Price: $ 16.00
Food Technology and Biotechnology
August 23, 2010 by biotech-source.com · Leave a Comment
Food Technology and Biotechnology
Official journal of the Croatian Society of Biotechnology and Slovenian Microbiologic Society.
Price: $ 120.00
Find More Products
The World According to Monsanto
June 18, 2010 by biotech-source.com · 4 Comments
The World According to Monsanto
- ISBN13: 9781595584267
- Condition: NEW
- Notes: Brand New from Publisher. No Remainder Mark.
Sends chills down the spine. . . . After reading this, we can no longer afford to turn a blind eye.
–Le Point
The result of a remarkable three-year-long investigation that took award-winning journalist and documentary filmmaker Marie-Monique Robin across four continents (North and South America, Europe, and Asia), The World According to Monsanto tells the little-known yet shocking story of this agribusiness giant–the world’s leading producer of GMOs (genetically modified organisms)–and how its new “green” face is no less malign than its PCB- and Agent Orange-soaked past.
Robin reports that, following its long history of manufacturing hazardous chemicals and lethal herbicides, Monsanto is now marketing itself as a “life sciences” company, seemingly convinced about the virtues of sustainable development. However, Monsanto now controls the majority of the yield of the world’s genetically modified corn and soy–ingredients found in more than 95 percent of American households–and its alarming legal and political tactics to maintain this monopoly are the subject of worldwide concern.
Released to great acclaim and controversy in France, throughout Europe, and in Latin America alongside the documentary film of the same name, The World According to Monsanto is sure to change the way we think about food safety and the corporate control of our food supply.
Rating:
(out of 4 reviews)
List Price: $ 26.95
Price: $ 17.72
More Products
MIT Technology Review – Biotech
June 18, 2010 by biotech-source.com · Leave a Comment
MIT Technology Review – Biotech
The MIT Technology Review – Biotech blog offers the latest on emerging information biotechnologies and the impact these technologies have on business and society.
Kindle blogs are fully downloaded onto your Kindle so you can read them even when you’re not wirelessly connected. And unlike RSS readers which often only provide headlines, blogs on Kindle give you full text content and images, and are updated wirelessly throughout the day.
List Price: $ 0.01
Price: $ 1.99
Find More Products
(AFX UK Focus) 2010-03-23 08:50 Merck KGaA to issue bonds regularly -CFO in paper
March 30, 2010 by biotech-source.com · Leave a Comment
(AFX UK Focus) 2010-03-23 08:50 Merck KGaA to issue bonds regularly -CFO in paper
FRANKFURT, March 23 (Reuters) – German pharmaceutical company Merck KGaA expects to raise funds on the bond market on a regular basis, its chief financial officer said in a newspaper interview. “Under our (bond) programme we will regularly act as an issuer on the bond market,” Michael Becker told Boersen-Zeitung in an interview published on Tuesday. Last week, Merck issued a 3.2 billion euro ($4 …
Read more on Interactive Investor




















